HB 1022 — Virginia
Prescription drug price transparency
Requires drug manufacturers to report and justify list-price increases above 10% in a single year.
Plain-language summary — a convenience. The full text below is the record.
Timeline
Introduced
Jan 14, 2026
House floor vote
Feb 3, 2026
Senate floor vote
Feb 24, 2026
Pending — Governor action
Sponsored by David Miles, Priya Shah
House of Delegates vote — 3–0
Passage · Feb 3, 2026
3 yea · 0 nay · 0 absent/abstain
Roll-call record — source link appears with live data
Senate vote — 1–1
Passage · Feb 24, 2026
1 yea · 1 nay · 1 absent/abstain
Roll-call record — source link appears with live data
View full bill text — Virginia Legislative Information System — source link appears with live data
Sample data. Every official, bill, vote and donation shown here is fictional, for design and testing. Live records from official sources replace it once the data pipeline is connected.